Detalhe da pesquisa
1.
A randomized phase 2 study of sapanisertib in combination with paclitaxel versus paclitaxel alone in women with advanced, recurrent, or persistent endometrial cancer.
Gynecol Oncol
; 178: 110-118, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37839313
2.
Distribution and Detectability of EGFR Exon 20 Insertion Variants in NSCLC.
J Thorac Oncol
; 18(6): 744-754, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36738930
3.
Brigatinib Versus Alectinib in ALK-Positive NSCLC After Disease Progression on Crizotinib: Results of Phase 3 ALTA-3 Trial.
J Thorac Oncol
; 18(12): 1743-1755, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37574132
4.
Dissecting genetic requirements of human breast tumorigenesis in a tissue transgenic model of human breast cancer in mice.
Proc Natl Acad Sci U S A
; 106(17): 7022-7, 2009 Apr 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-19369208
5.
Survival Outcomes and Treatment Patterns in Patients With NFE2L2 and/or KEAP1 Mutation-Positive Advanced Squamous Cell NSCLC Using a Real-World Clinico-Genomic Database.
Clin Lung Cancer
; 23(6): 487-497, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35705448
6.
Sapanisertib plus Fulvestrant in Postmenopausal Women with Estrogen Receptor-Positive/HER2-Negative Advanced Breast Cancer after Progression on Aromatase Inhibitor.
Clin Cancer Res
; 28(6): 1107-1116, 2022 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34980598
7.
Sapanisertib Plus Exemestane or Fulvestrant in Women with Hormone Receptor-Positive/HER2-Negative Advanced or Metastatic Breast Cancer.
Clin Cancer Res
; 27(12): 3329-3338, 2021 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33820779
8.
Activity and Safety of Mobocertinib (TAK-788) in Previously Treated Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations from a Phase I/II Trial.
Cancer Discov
; 11(7): 1688-1699, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33632775
9.
Treatment Outcomes and Safety of Mobocertinib in Platinum-Pretreated Patients With EGFR Exon 20 Insertion-Positive Metastatic Non-Small Cell Lung Cancer: A Phase 1/2 Open-label Nonrandomized Clinical Trial.
JAMA Oncol
; 7(12): e214761, 2021 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34647988
10.
Mobocertinib (TAK-788): A Targeted Inhibitor of EGFR Exon 20 Insertion Mutants in Non-Small Cell Lung Cancer.
Cancer Discov
; 11(7): 1672-1687, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33632773
11.
Targeting HER2 Exon 20 Insertion-Mutant Lung Adenocarcinoma with a Novel Tyrosine Kinase Inhibitor Mobocertinib.
Cancer Res
; 81(20): 5311-5324, 2021 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34380634
12.
Translational strategy using multiple nuclear imaging biomarkers to evaluate target engagement and early therapeutic efficacy of SAR439859, a novel selective estrogen receptor degrader.
EJNMMI Res
; 10(1): 70, 2020 Jun 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-32601772
13.
Response to "NGS, the New Global Standard?"
J Thorac Oncol
; 18(10): e116-e118, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37758351
14.
Targeting of proteins to membranes through hedgehog auto-processing.
Nat Biotechnol
; 21(8): 936-40, 2003 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-12858181
15.
Neuregulin 1 expression is a predictive biomarker for response to AV-203, an ERBB3 inhibitory antibody, in human tumor models.
Clin Cancer Res
; 21(5): 1106-14, 2015 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25542901
16.
Papillary tumor of the pineal region.
Am J Surg Pathol
; 27(4): 505-12, 2003 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-12657936
17.
Integrated version of reverse two-hybrid system for the postproteomic era.
Methods Enzymol
; 350: 525-45, 2002.
Artigo
em Inglês
| MEDLINE | ID: mdl-12073334
18.
Microphthalmia transcription factor analysis in posterior uveal melanomas.
Exp Eye Res
; 76(6): 653-61, 2003 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-12742347
19.
Calbindin-d(28k): a marker of recurrence for medulloblastomas.
Cancer
; 95(2): 410-9, 2002 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-12124842
20.
O indivíduo na organização: dimensões esquecidas / The individual in the organization: dimensions forgotten
São Paulo; Atlas; 1996. 300 p. ilus.
Monografia
em Português
| LILACS | ID: lil-407240